Literature DB >> 21093891

Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients.

Aydan Eroğlu, Nejat Akar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093891     DOI: 10.1016/j.thromres.2010.10.025

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  1 in total

1.  MTHFR 677C>T polymorphism and the risk of breast cancer: evidence from an original study and pooled data for 28031 cases and 31880 controls.

Authors:  Singh Pooja; Justin Carlus; Deepa Sekhar; Amirtharaj Francis; Nishi Gupta; Rituraj Konwar; Sandeep Kumar; Surender Kumar; Kumarasamy Thangaraj; Singh Rajender
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.